Dun & Bradstreet (DNB) Prices 78.3M Share IPO at $22/Sh

Dun & Bradstreet Holdings, Inc. (NYSE: DNB) today announced the pricing of its initial public offering of 78,302,272 shares of common stock at an initial public offering price of $22.00 per share. The shares are expected to begin trading on the New York Stock Exchange on July 1, 2020 under the symbol "DNB." The initial public offering is expected to close on July 6, 2020, subject to the satisfaction of customary closing conditions.

In addition, the underwriters have been granted a 30-day option to purchase up to an additional 11,745,340 shares at the initial public offering price, less underwriting discounts and commissions.

A subsidiary of Cannae Holdings, Inc., a subsidiary of Black Knight, Inc., and a subsidiary of CC Capital Partners, LLC plan to invest $200.0 million, $100.0 million, and $100.0 million, respectively, in a concurrent private placement of Dun & Bradstreet's common stock at a price per share equal to $21.67. Such concurrent private placement is contingent upon the consummation of the offering. Dun & Bradstreet intends to use the proceeds that it receives from the offering and the concurrent private placement to redeem all of its outstanding Series A Preferred Stock, repay a portion of its 10.250% Senior Unsecured Notes outstanding due 2027 and for working capital and other general corporate purposes, which may include the repayment of additional indebtedness.

Goldman Sachs & Co. LLC, BofA Securities, J.P. Morgan and Barclays are acting as joint lead book running managers and representatives of the underwriters for the offering. Citigroup, Credit Suisse, HSBC, Jefferies, RBC Capital Markets, Wells Fargo Securities, Deutsche Bank Securities, BMO Capital Markets, SunTrust Robinson Humphrey and TD Securities are also acting as book-running managers for the offering. William Blair, Raymond James, Stephens Inc., Academy Securities and Loop Capital Markets are acting as co-managers for the offering.

You May Also Be Interested In

• Oura IPO said to draw four times demand as orders near close
• William Blair Downgrades Stitch Fix, Inc. (SFIX) to Market Perform
• Viking Therapeutics prices $500M stock and convertible notes offering